JP2006524511A5 - - Google Patents

Download PDF

Info

Publication number
JP2006524511A5
JP2006524511A5 JP2006513300A JP2006513300A JP2006524511A5 JP 2006524511 A5 JP2006524511 A5 JP 2006524511A5 JP 2006513300 A JP2006513300 A JP 2006513300A JP 2006513300 A JP2006513300 A JP 2006513300A JP 2006524511 A5 JP2006524511 A5 JP 2006524511A5
Authority
JP
Japan
Prior art keywords
seq
virus
recombinant
parainfluenza virus
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006513300A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006524511A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/012723 external-priority patent/WO2005027825A2/en
Publication of JP2006524511A publication Critical patent/JP2006524511A/ja
Publication of JP2006524511A5 publication Critical patent/JP2006524511A5/ja
Pending legal-status Critical Current

Links

JP2006513300A 2003-04-25 2004-04-23 メタニューモウイルス由来の異種抗原を含む組換えパラインフルエンザウイルス発現系およびワクチン Pending JP2006524511A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US46618103P 2003-04-25 2003-04-25
US49927403P 2003-08-28 2003-08-28
US55093104P 2004-03-05 2004-03-05
PCT/US2004/012723 WO2005027825A2 (en) 2003-04-25 2004-04-23 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011084567A Division JP2011167197A (ja) 2003-04-25 2011-04-06 メタニューモウイルス由来の異種抗原を含む組換えパラインフルエンザウイルス発現系およびワクチン

Publications (2)

Publication Number Publication Date
JP2006524511A JP2006524511A (ja) 2006-11-02
JP2006524511A5 true JP2006524511A5 (cg-RX-API-DMAC7.html) 2007-06-14

Family

ID=34381928

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006513300A Pending JP2006524511A (ja) 2003-04-25 2004-04-23 メタニューモウイルス由来の異種抗原を含む組換えパラインフルエンザウイルス発現系およびワクチン
JP2011084567A Ceased JP2011167197A (ja) 2003-04-25 2011-04-06 メタニューモウイルス由来の異種抗原を含む組換えパラインフルエンザウイルス発現系およびワクチン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011084567A Ceased JP2011167197A (ja) 2003-04-25 2011-04-06 メタニューモウイルス由来の異種抗原を含む組換えパラインフルエンザウイルス発現系およびワクチン

Country Status (9)

Country Link
US (2) US20050142148A1 (cg-RX-API-DMAC7.html)
EP (1) EP1622574A4 (cg-RX-API-DMAC7.html)
JP (2) JP2006524511A (cg-RX-API-DMAC7.html)
KR (2) KR101187955B1 (cg-RX-API-DMAC7.html)
CN (1) CN1813061B (cg-RX-API-DMAC7.html)
AU (1) AU2004273776B2 (cg-RX-API-DMAC7.html)
CA (1) CA2523657A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA05011268A (cg-RX-API-DMAC7.html)
WO (1) WO2005027825A2 (cg-RX-API-DMAC7.html)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030232061A1 (en) * 2001-10-18 2003-12-18 Fouchier Ronaldus Adrianus Maria Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
US8715922B2 (en) * 2001-01-19 2014-05-06 ViroNovative Virus causing respiratory tract illness in susceptible mammals
US20040096451A1 (en) * 2002-07-25 2004-05-20 Young James F. Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodies
DK1351981T3 (da) 2001-01-19 2012-11-26 Vironovative Bv Et virus, der forårsager luftvejssygdom hos modtagelige pattedyr
TWI344991B (en) 2002-02-21 2011-07-11 Medimmune Vaccines Inc Metapneumovirus strains as vaccine formulations and as vectors for expression of heterologous antigenic sequences
CN101410519B (zh) * 2003-04-25 2013-04-24 免疫医疗有限责任公司 间质肺病毒株及其在疫苗制剂中以及用作抗原性序列表达载体的用途和繁殖病毒的方法
CN101548009A (zh) * 2005-03-10 2009-09-30 米迪缪尼有限公司 偏肺病毒株及其在疫苗制备和作为抗原序列表达载体的应用以及增殖该病毒的方法
JP2009501520A (ja) * 2005-07-14 2009-01-22 メイヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチ パラミクソウイルス科ウイルス調製物
US20090017517A1 (en) * 2007-07-13 2009-01-15 Medimmune, Llc Preparation of Negative-Stranded RNA Viruses by Electroporation
US20090186050A1 (en) * 2007-11-16 2009-07-23 Fouchier Ron A M Live attenuated metapneumovirus strains and their use in vaccine formulations and chimeric metapneumovirus strains
ES2987238T3 (es) 2008-12-09 2024-11-14 Novavax Inc Proteínas F del RSV modificadas y métodos de su uso
US11446374B2 (en) 2008-12-09 2022-09-20 Novavax, Inc. Modified RSV F proteins and methods of their use
SG176807A1 (en) * 2009-06-24 2012-01-30 Id Biomedical Corp Quebec Vaccine
KR101073991B1 (ko) * 2009-10-27 2011-10-21 대한민국 국내사육 닭에서 유행하는 신규한 b형 조류메타뉴모바이러스 sc1509주 및 이의 용도
SG10201602434UA (en) * 2011-09-30 2016-05-30 Novavax Inc Recombinant nanoparticle rsv f vaccine for respiratory syncytial virus
JP6132420B2 (ja) * 2011-10-25 2017-05-24 国立大学法人岐阜大学 変異狂犬病ウイルス合成・増殖方法、並びに狂犬病ワクチン製剤
GB201119032D0 (en) * 2011-11-03 2011-12-14 Isis Innovation Multisomes: encapsulated droplet networks
JP6358706B2 (ja) * 2012-12-26 2018-07-18 バイオコモ株式会社 ヒトパラインフルエンザ2型ウイルスベクターを利用したワクチン
EP4421177A3 (en) 2013-03-13 2024-12-18 The United States of America, as represented by the Secretary, Department of Health and Human Services Prefusion rsv f proteins and their use
WO2014145968A2 (en) * 2013-03-15 2014-09-18 The Regents Of The University Of California Rna interference functions as an antiviral immunity in mammals
CL2013002829A1 (es) * 2013-10-01 2014-04-04 Univ Pontificia Catolica Chile Formulacion inmunogenica que contiene bcg vivas recombinantes que expresan antigenos de metapneumovirus (hmpv) en una suspension que se prepara a partir de un liofilizado sin la necesidad de adjuvante; su uso farmaceutico; vacuna contra hmpv.
JP6589159B2 (ja) * 2014-04-01 2019-10-16 共立製薬株式会社 新規ネコモルビリウイルス株、不活化ワクチン製剤、並びにネコモルビリウイルス感染症予防方法
EP3247388B1 (en) 2015-01-20 2025-09-10 The United States of America, as represented by The Secretary, Department of Health and Human Services Recombinant human/bovine parainfluenza virus 3 (b/hpiv3) expressing a chimeric rsv/bpiv3 f protein and uses thereof
CN114617959A (zh) 2015-09-03 2022-06-14 诺瓦瓦克斯股份有限公司 具有改进的稳定性和免疫原性的疫苗组合物
DE20164728T1 (de) 2015-10-22 2021-09-30 Modernatx, Inc. Impfstoffe gegen atemwegsvirus
CN115960263A (zh) 2016-03-29 2023-04-14 美国政府(由卫生和人类服务部的部长所代表) 取代修饰的融合前rsv f蛋白及其用途
EP3551193A4 (en) * 2016-12-08 2020-08-19 Modernatx, Inc. NUCLEIC ACID VACCINES AGAINST RESPIRATORY VIRUSES
WO2018109220A2 (en) 2016-12-16 2018-06-21 Institute For Research In Biomedicine Novel recombinant prefusion rsv f proteins and uses thereof
EP3630173A1 (en) 2017-05-29 2020-04-08 The United States of America, as represented by the Secretary, Department of Health and Human Services Recombinant chimeric bovine/human parainfluenza virus 3 expressing rsv g and its use
CN111148509A (zh) 2017-07-24 2020-05-12 诺瓦瓦克斯股份有限公司 治疗呼吸系统疾病的方法和组合物
CN120227451A (zh) 2018-03-19 2025-07-01 诺瓦瓦克斯股份有限公司 多价流感纳米颗粒疫苗
US11351242B1 (en) 2019-02-12 2022-06-07 Modernatx, Inc. HMPV/hPIV3 mRNA vaccine composition
TWI708877B (zh) 2019-10-18 2020-11-01 福懋興業股份有限公司 導電布及其製備方法與應用
CN111961652A (zh) * 2020-07-09 2020-11-20 温氏食品集团股份有限公司 一种禽偏肺病毒的无血清全悬浮培养方法及其在疫苗中的应用
US20240197861A1 (en) 2021-04-27 2024-06-20 The U.S.A., As Represented By The Secretary, Department Of Health And Human Services Recombinant chimeric bovine/human parainfluenza virus 3 expressing sars-cov-2 spike protein and its use
CN113593639B (zh) * 2021-08-05 2023-08-25 湖南大学 一种用于病毒基因组变异分析、监测方法和系统
JP2024544054A (ja) 2021-11-30 2024-11-27 サノフィ パスツール インコーポレイテッド ヒトメタニューモウイルスのウイルスベクターに基づくワクチン
WO2023215727A2 (en) * 2022-05-02 2023-11-09 The Regents Of The University Of California Multicomponent systems for site-specific genome modifications
WO2026003578A1 (en) * 2024-06-26 2026-01-02 Popvax Private Limited Multisubunit rsv, hmpv and hpiv vaccines and therapeutics
WO2026003579A1 (en) * 2024-06-27 2026-01-02 Popvax Private Limited Multisubunit papillomavirus vaccines and therapeutics
WO2026080706A1 (en) 2024-10-10 2026-04-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Recombinant chimeric bovine/human parainfluenza virus 3 expressing avian influenza virus proteins and use thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166057A (en) * 1989-08-28 1992-11-24 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand rna virus expression-systems
US5854037A (en) * 1989-08-28 1998-12-29 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand RNA virus expression systems and vaccines
US5824307A (en) * 1991-12-23 1998-10-20 Medimmune, Inc. Human-murine chimeric antibodies against respiratory syncytial virus
US5869036A (en) * 1995-12-08 1999-02-09 St. Louis University Live attenuated vaccines based on CP45 HPIV-3 strain and method to ensure attenuation in such vaccine
US6180398B1 (en) * 1996-07-12 2001-01-30 Virogeneitics Corporation Two-step immunization procedure against the pyramyxoviridae family of viruses using recombinant virus and subunit protein preparation
US7192593B2 (en) * 1997-05-23 2007-03-20 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens
US6656719B1 (en) 1997-10-27 2003-12-02 Merck & Co., Inc. Serum-free, low-protein media for rotavirus vaccine production
US6146642A (en) * 1998-09-14 2000-11-14 Mount Sinai School Of Medicine, Of The City University Of New York Recombinant new castle disease virus RNA expression systems and vaccines
WO2000070070A1 (en) * 1999-05-18 2000-11-23 Dnavec Research Inc. Paramyxoviridae virus vector defective in envelope gene
CA2378661A1 (en) * 1999-07-09 2001-01-18 Alexander C. Schmidt Attenuated human-bovine chimeric parainfluenza virus (piv) vaccines
EP1103610A1 (en) * 1999-11-26 2001-05-30 Introgene B.V. Production of vaccines from immortalised mammalian cell lines
DK1351981T3 (da) * 2001-01-19 2012-11-26 Vironovative Bv Et virus, der forårsager luftvejssygdom hos modtagelige pattedyr
US20030232061A1 (en) * 2001-10-18 2003-12-18 Fouchier Ronaldus Adrianus Maria Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
US8715922B2 (en) * 2001-01-19 2014-05-06 ViroNovative Virus causing respiratory tract illness in susceptible mammals
ATE509097T1 (de) * 2001-11-21 2011-05-15 Us Health Gewinnung von rekombinantem menschlichem parainfluenzavirus typ 1 (hpivi) aus cdna
TWI344991B (en) * 2002-02-21 2011-07-11 Medimmune Vaccines Inc Metapneumovirus strains as vaccine formulations and as vectors for expression of heterologous antigenic sequences
JP2007524372A (ja) * 2003-02-28 2007-08-30 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ 組換えヒトメタニューモウイルスおよびその使用
CN101410519B (zh) * 2003-04-25 2013-04-24 免疫医疗有限责任公司 间质肺病毒株及其在疫苗制剂中以及用作抗原性序列表达载体的用途和繁殖病毒的方法
WO2005007078A2 (en) * 2003-04-30 2005-01-27 The Boards Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method of inhibiting human metapneumovirus and human coronavirus in the prevention and treatment of severe acute respiratory syndrome (sars)

Similar Documents

Publication Publication Date Title
Huang et al. Genomic sequence of an isolate of Newcastle disease virus isolated from an outbreak in geese: a novel six nucleotide insertion in the non-coding region of the nucleoprotein gene
Biacchesi et al. Recombinant human metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate
Liu et al. Pathotypical and genotypical characterization of strains of Newcastle disease virus isolated from outbreaks in chicken and goose flocks in some regions of China during 1985–2001
US12054749B2 (en) Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization
US12054519B2 (en) Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes
JP2004531220A5 (cg-RX-API-DMAC7.html)
CN113293145B (zh) 一种麻疹病毒活载体新冠疫苗
CN113293148B (zh) 一种h基因替换的嵌合麻疹减毒株的构建
CN113293149B (zh) 一种f基因替换的嵌合麻疹减毒株的构建
CN101248174A (zh) 减毒的sars以及作为疫苗的用途
CN107635579A (zh) 非天然发生的猪生殖和呼吸综合征病毒(prrsv)和使用方法
JP2011521648A5 (cg-RX-API-DMAC7.html)
JP2020522249A5 (cg-RX-API-DMAC7.html)
WO2006024543A1 (en) Vaccine against severe accute respiratory syndrome causing coronavirus (sars-cov)
JP2018536428A5 (cg-RX-API-DMAC7.html)
CN103757032B (zh) 一种以流感病毒为载体的hcv嵌合疫苗及其制备方法
CN119101704A (zh) 一种稳定敲除ifitm1基因的HepG2.215细胞系构建方法及其应用
CN113304256B (zh) 非洲猪瘟病毒d205r和d345l基因的应用
CN117886950A (zh) 呼吸道合胞病毒假病毒及其制备方法
CN115887634A (zh) 鸡传染性支气管炎二价亚单位疫苗及应用
JP2023529836A5 (cg-RX-API-DMAC7.html)
CN120775802B (zh) 一种鲤疱疹病毒3型orf136基因失活株及其制备方法和应用
Kanojia et al. Amplification and cloning of rabies virus virulent glycoprotein gene in pAlpha vector
Chouljenko et al. Elucidation of the genomic nucleotide sequence of bovine coronavirus and analysis of cryptic leader mRNA fusion sites
US7510863B2 (en) Avian pneumovirus genes, recombinant avian pneumoviruses and methods of making